Polymorphisms in genes of respiratory control and sudden infant death syndrome

Katharina Läer1, Thilo Dörk, Marielle Vennemann

  • 1Institute of Legal Medicine, Hannover Medical School, Carl-Neuberg-Str.1, D-30625, Hannover, Germany.

Insights

Genetic variations in respiratory control may contribute to Sudden Infant Death Syndrome (SIDS). This study found potential links between specific gene polymorphisms and seasonal SIDS cases, but further research is needed.

Area of Science:

  • Genetics
  • Pediatrics
  • Respiratory Physiology

Background:

  • Sudden Infant Death Syndrome (SIDS) is a complex condition often linked to respiratory control deficits.
  • Failure in arousal and autoresuscitation during homeostatic challenges like hypoxia may play a role.
  • Genetic factors influencing respiratory control in the medulla oblongata are hypothesized contributors to SIDS.

Purpose of the Study:

  • To investigate the association between genetic polymorphisms in candidate genes and SIDS.
  • To identify specific gene variants that may increase SIDS risk.

Main Methods:

  • Genotyping of 48 single nucleotide polymorphisms (SNPs) in 41 candidate genes.
  • Analysis of 366 SIDS cases and 421 controls using Fluidigm nanofluidic technology.
  • Statistical analysis with correction for multiple testing.

Main Results:

  • One SNP (rs1801030) in the phenol sulfotransferase 1A1 gene showed nominal association with seasonal SIDS (summer deaths).
  • A borderline association was observed for rs563649 in the opioid receptor μ1 gene (recessive model, autumn deaths).
  • No single SNP fully explained the multifactorial etiology of SIDS.

Conclusions:

  • The study suggests potential associations between specific SNPs and distinct subgroups of SIDS cases.
  • Findings underscore the complex, multifactorial nature of SIDS.
  • Further investigation into genes involved in the respiratory system is warranted.

Related Concept Videos

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
69
Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
19.9K
Exon Recombination02:32

Exon Recombination

The evolution of new genes is critical for speciation. Exon recombination, also known as exon shuffling or domain shuffling, is an important means of new gene formation. It is observed across vertebrates, invertebrates, and in some plants such as potatoes and sunflowers. During exon recombination, exons from the same or different genes recombine and produce new exon-intron combinations, which might evolve into new genes. 
Exon shuffling follows “splice frame rules.” Each exon...
4.3K
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
116
Comparing Copy Number Variations and SNPs02:26

Comparing Copy Number Variations and SNPs

Sequencing of the human genome has opened up several best-kept secrets of the genome. Scientists have identified thousands of genome variations that exist within a population. These variations can be a single nucleotide or a larger chromosomal variation.
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
19.3K